Bed Bath & Beyond (BBBY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Voting matters and shareholder proposals
Election of seven directors, with nominees listed and board recommending a vote FOR all.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory (non-binding) approval of executive compensation for named executive officers.
Approval of amendment to increase authorized shares of common stock.
Approval of adjournment of the meeting if more time is needed to solicit votes for Proposals 4 and/or 6.
Approval of amendment and restatement of the 2005 Equity Incentive Plan.
Board of directors and corporate governance
Seven director nominees are presented for election, with board support for each.
Audit committee and external auditor matters
Proposal to ratify KPMG LLP as the external auditor for the upcoming fiscal year.
Latest events from Bed Bath & Beyond
- Key votes include director elections, auditor ratification, and major equity and governance proposals.BBBY
Proxy filing27 Mar 2026 - Stockholders will vote on director elections, auditor ratification, compensation, and key governance changes.BBBY
Proxy Filing17 Mar 2026 - Margins and EBITDA improved for eight quarters; 2026 targets growth and profitability.BBBY
Q4 202523 Feb 2026 - Sequential margin and EBITDA improved 25% as active customers rose 35% to 6.2M.BBBY
Q2 20242 Feb 2026 - Data-driven, asset-light strategy with new licensing deals aims to boost profitability and brand reach.BBBY
Piper Sandler Growth Frontiers Conference21 Jan 2026 - Revenue down 16.6%, losses persist, but active customers up 21% amid cost cuts and investments.BBBY
Q3 2024 & Investor Update18 Jan 2026 - Q1 2025 revenue fell 39% but gross margin rose to 25.1% as losses narrowed and growth is expected.BBBY
Q1 20253 Jan 2026 - Gross margin rose to 23% and adjusted EBITDA loss improved, despite a 21% revenue decline.BBBY
Q4 202418 Dec 2025 - Shareholders receive warrants to buy shares at $15.50, with proceeds for general corporate use.BBBY
Registration Filing16 Dec 2025